Custom service

Peptide Spin Labels

Attach nitroxide and other paramagnetic labels for epr studies

Turnaround: 3–5 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: MTSL and TOAC incorporation; site-directed spin labeling; reduction-resistant label variants

The service is built around MTSL and TOAC incorporation. Depending on the molecule we may move to site-directed spin labeling or reduction-resistant label variants to improve stability, loading or yield, and every batch is released with spin-labeled peptide with label-ratio QC.

Because Peptide Spin Labels projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Distance constraints by DEER-EPR

Membrane dynamics studies

In-vivo EPR applications where label stability is critical

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • MTSL and TOAC incorporation as the default route, with site-directed spin labeling held as a proven fallback
  • Reduction-resistant label variants worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Spin-labeled peptide with label-ratio QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — MTSL and TOAC incorporation, site-directed spin labeling — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Spin-labeled peptide with label-ratio QC is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
3–5 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
MTSL and TOAC incorporation; site-directed spin labeling; reduction-resistant label variants
Deliverable
Spin-labeled peptide with label-ratio QC
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.